RFID Enhances Drug Traceability and Supports DSCSA Compliance

New developments in radio frequency identification (RFID) standards are making it easier for healthcare organizations to meet the requirements of the Drug Supply Chain Security Act (DSCSA), which mandates full electronic tracking of prescription drugs throughout the supply chain.

The DSCSA was introduced to improve drug safety by ensuring medications can be traced at every stage—from manufacturers to patients—helping prevent counterfeit or unsafe products from entering circulation.  

A key factor behind recent progress is the evolution of global data standards from GS1. These standards provide a common framework for identifying and sharing product information across supply chain partners worldwide.

With updated RFID guidelines, pharmaceutical companies can now encode critical data—such as product identifiers, lot numbers, expiration dates, and serial numbers—directly into tags. This makes essential information easier to access and supports compliance with DSCSA requirements.  

Recent updates, including newer versions of GS1’s tag data standards, significantly improve how information is stored and retrieved. Key product details are now embedded in a way that allows quick and direct access, eliminating the need for proprietary systems or paid databases.

This improved accessibility enables healthcare providers and supply chain partners to quickly identify expired or compromised drugs and remove them before reaching patients, enhancing both efficiency and safety.  

Further advancements also allow RFID tags to include links to additional product information, such as storage requirements or handling instructions. This gives stakeholders better visibility at every stage of distribution and helps ensure proper handling of sensitive medications.

By relying on standardized, interoperable data, organizations can achieve greater transparency and coordination across the pharmaceutical supply chain.